Heuron gets FDA green light for stroke triage and notification solution
This marks the first FDA approval of an AI-based brain disorder analysis solution from Korea
This marks the first FDA approval of an AI-based brain disorder analysis solution from Korea
Phase I data for tuvusertib, lead asset from the company’s unique portfolio of DDR inhibitors
The combined entity will enable us to better serve the needs of patients, healthcare professionals and our customers around the world
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
Launch of 20 new medicines expected by 2030
ASG Group of Eye Hospitals has 165+ branches in 85+ cities across India and abroad
The collaboration aims to bolster healthcare entrepreneurship
SUPERNOVA is a large Phase III global trial providing the only efficacy data in immunocompromised patients
The award recognizes powerful science–industry collaborations for social good
Subscribe To Our Newsletter & Stay Updated